Order Article Reprints

Kim EL, Sorokin M, Kantelhardt SR, Kalasauskas D, Sprang B, Fauss J, Ringel F, Garazha A, Albert E, Gaifullin N, et al. Intratumoral Heterogeneity and Longitudinal Changes in Gene Expression Predict Differential Drug Sensitivity in Newly Diagnosed and Recurrent Glioblastoma. Cancers. 2020; 12(2):520. https://doi.org/10.3390/cancers12020520

Kim, Ella L., Maxim Sorokin, Sven Rainer Kantelhardt, Darius Kalasauskas, Bettina Sprang, Julian Fauss, Florian Ringel, Andrew Garazha, Eugene Albert, Nurshat Gaifullin, and et al. 2020. "Intratumoral Heterogeneity and Longitudinal Changes in Gene Expression Predict Differential Drug Sensitivity in Newly Diagnosed and Recurrent Glioblastoma" Cancers 12, no. 2: 520. https://doi.org/10.3390/cancers12020520

Kim, E. L., Sorokin, M., Kantelhardt, S. R., Kalasauskas, D., Sprang, B., Fauss, J., Ringel, F., Garazha, A., Albert, E., Gaifullin, N., Hartmann, C., Naumann, N., Bikar, S.-E., Giese, A., & Buzdin, A. (2020). Intratumoral Heterogeneity and Longitudinal Changes in Gene Expression Predict Differential Drug Sensitivity in Newly Diagnosed and Recurrent Glioblastoma. Cancers, 12(2), 520. https://doi.org/10.3390/cancers12020520